Medical News

RSS

Gastroenteropancreatic neuroendocrine tumors: an interview with Dr. Alexandria Phan

GEP-NETs stands for gastroenteropancreatic (GEP) neuroendocrine tumors (NETs). This is a type of rare cancer that is increasing in incidence and prevalence – more on this later.

22 Oct 2014

Telstra launches vision for a more connected healthcare system

Today Telstra officially launched a new business division, Telstra Health, and outlined its ambition to become Australia’s leading provider of integrated eHealth solutions.

21 Oct 2014

Crown Bioscience announces U.S. expansion with new translational oncology center

Crown Bioscience, Inc., a leading global drug discovery and development service company, has announced the opening of the Crown Bioscience US Research Center to be located at the David H. Murdock Research Institute (DHMRI), in Kannapolis, N.C. The new center, which will open in the 3rd quarter of 2014, represents significant U.S. market expansion for Crown.

21 Oct 2014

Next generation sequencing applications automated through partnership between Beckman Coulter Life Sciences and New England Biolabs

Beckman Coulter Life Sciences, through a partnership with New England Biolabs®, Inc.

From Beckman Coulter Life Sciences - Automation and Genomics 21 Oct 2014

GE Healthcare’s advances in imaging quantitation may help clinicians diagnose disease earlier

GE Healthcare shares a suite of advances in imaging quantitation that may help clinicians diagnose disease earlier, deliver more personalised treatment and speed up care at the 27th annual meeting of the European Association of Nuclear Medicine (EANM), 18-22 October, in Gothenburg.

21 Oct 2014

Early access program for human chromosome mapping analytical service announced by Hitachi High-Technologies Corporation and OpGen

Hitachi High-Technologies Corporation and OpGen, Inc., a leading genetic analysis company, announced the introduction of an Early Access Program for its upcoming Human Chromosome ExplorerSM, human chromosome mapping analytical service for clinical research and life science research applications.

21 Oct 2014

Research: MHCI protein moonlights in nervous system to regulate synapses

When it comes to the brain, "more is better" seems like an obvious assumption. But in the case of synapses, which are the connections between brain cells, too many or too few can both disrupt brain function.

21 Oct 2014

State highlights: Calif. ballot measure updates; Va. prison health care budget shortfall

A selection of health policy stories from California, Arizona, Maine, South Dakota, Virginia, Maryland, Louisiana, Pennsylvania, Massachusetts, North Carolina, Texas, Washington state and Missouri.

21 Oct 2014

YEDA and XL-protein sign deal to commercialize PASylated IFN superagonis

YEDA Research and Development Company Ltd., the technology transfer arm of the Weizmann Institute of Science, Israel, and XL-protein GmbH, Germany, a privately owned biopharmaceutical company, have signed a business collaboration agreement to commercialize a PASylated interferon superagonist -- PAS-YNSα8 -- which has been jointly developed by scientists at the Weizmann Institute and XL-protein.

21 Oct 2014

Hospitals demand TRU-D SmartUVC device to be added to Ebola protocols

Following the tragic infections of two hospital staff and subsequent tracking of hundreds of people related to Ebola, hospitals around the country are requiring TRU-D SmartUVC, a portable automated UVC disinfection robot which accurately measures required dosage, be added to Ebola protocols.

21 Oct 2014

New electronic EyeCane improves mobility of blind people

White Canes provide low-tech assistance to the visually impaired, but some blind people object to their use because they are cumbersome, fail to detect elevated obstacles, or require long training periods to master.

21 Oct 2014

Couple renews multi-million dollar commitment to screen newborn babies for SCID disorders

Frustrated with the slow pace of implementation of Newborn Screening for Severe Combined Immune Deficiency (SCID), Vicki and Fred Modell renewed a multi-million dollar commitment to screen every baby born in every state for this life threatening condition, often referred to as "Bubble Boy" disease.

21 Oct 2014

Medical News

Gastroenteropancreatic neuroendocrine tumors: an interview with Dr. Alexandria Phan

Telstra launches vision for a more connected healthcare system

Crown Bioscience announces U.S. expansion with new translational oncology center

Next generation sequencing applications automated through partnership between Beckman Coulter Life Sciences and New England Biolabs

GE Healthcare’s advances in imaging quantitation may help clinicians diagnose disease earlier

Early access program for human chromosome mapping analytical service announced by Hitachi High-Technologies Corporation and OpGen

Research: MHCI protein moonlights in nervous system to regulate synapses

State highlights: Calif. ballot measure updates; Va. prison health care budget shortfall

YEDA and XL-protein sign deal to commercialize PASylated IFN superagonis

Hospitals demand TRU-D SmartUVC device to be added to Ebola protocols

New electronic EyeCane improves mobility of blind people

Couple renews multi-million dollar commitment to screen newborn babies for SCID disorders

The Jackson Laboratory gets $10M to build new center for genomics and computational biology

Few California inmates with hepatitis C get costly Sovaldi

New book addresses legal issues for personal injury victims

Marken to expand global cold chain network to meet demand for packaging solutions

Omeros provides update on OMS824 for treatment of schizophrenia, Huntington's disease

Beacon Hill Pharma opens second location in Wakefield, MA

Viewpoints: Health care opponent's legal strategy; the challenge for this open enrollment

Maternal nutrition before conception important to improve offspring’s health, say researchers

Advancing Drug Safety Assessment With AI, Predictive Modeling, and Human-Relevant Data

AI-powered analytics and experimental validation

Membrane proteins in focus: Turning high-risk targets into routine workflows

Latest News